TNF-α genetic polymorphism -308G/A and antituberculosis drug-induced hepatitis. (Q53395242)

13 May 2018

title

TNF-α genetic polymorphism -308G/A and antituberculosis drug-induced hepatitis. (English)

1 reference

13 May 2018

0 references

8

1 reference

13 May 2018

author name string

Sang-Heon Kim

1

1 reference

13 May 2018

Sang-Hoon Kim

2

1 reference

13 May 2018

Ho Joo Yoon

3

1 reference

13 May 2018

Dong Ho Shin

4

1 reference

13 May 2018

Sung Soo Park

5

1 reference

13 May 2018

Youn-Seup Kim

6

1 reference

13 May 2018

Jae-Seuk Park

7

1 reference

13 May 2018

publication date

9 December 2011

1 reference

13 May 2018

published in

Liver International

1 reference

13 May 2018

volume

32

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

809-814

1 reference

13 May 2018

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

An official ATS statement: hepatotoxicity of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Antituberculosis drugs and hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

A fresh look at the mechanism of isoniazid-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Role of neutrophils in a mouse model of halothane-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Acetaminophen hepatotoxicity and acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Drug hypersensitivity: pharmacogenetics and clinical syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Pharmacogenetics of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

The role of cytokines in the mechanism of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Cytokine regulation of liver injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1 Potential role of inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Drug-induced liver injury: insights from genetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02697.X

10.1111/J.1478-3231.2011.02697.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

22151084

1 reference

13 May 2018